IVF Market Size & Forecast 2025–2033

The global In Vitro Fertilization (IVF) Market, valued at US$ 26.43 billion in 2024, is projected to reach US$ 49.12 billion by 2033, expanding at a CAGR of 7.13% during 2025–2033. This robust growth is powered by rising infertility rates, technological advancements in assisted reproductive technology, expanding medical tourism, and growing awareness about reproductive health worldwide.

According to Renub Research, the IVF Market & Forecast report covers detailed segmentation by procedure type, instruments, technique, surgery, end users, and a comprehensive analysis of key countries and companies.

Understanding the IVF Market

What is IVF?

In vitro fertilization (IVF) is one of the most advanced and effective reproductive treatments available today. It involves fertilizing an egg with sperm outside the human body—usually in a laboratory dish. Once fertilization occurs successfully, the embryo is implanted into the uterus with the aim of establishing a pregnancy.

This technology is widely used to address issues such as:

Blocked fallopian tubes

Male-factor infertility (low sperm count or quality)

Ovulation disorders

Unexplained infertility

Fertility preservation for medical or personal reasons

Conception for single parents and same-sex couples

Genetic disease prevention via preimplantation genetic testing (PGT)

IVF has gradually evolved into a sophisticated, accessible solution that helps millions achieve parenthood every year. Technological improvements, regulatory support in certain countries, and rising social acceptance have all contributed to its rapid global uptake.

Key Drivers Fueling Growth in the IVF Industry

1. Rising Global Infertility Rates

Infertility has become increasingly prevalent due to:

Delayed pregnancies

Lifestyle factors (stress, alcohol, smoking)

Obesity

Environmental toxins

Hormonal disorders

A 2023 WHO report revealed that approximately 17.5% of adults—1 in 6 globally—experience infertility, highlighting a critical need for accessible fertility care. This surge directly fuels IVF adoption, making it one of the fastest-growing segments in reproductive healthcare.

Improved diagnostics and increased social acceptance have further encouraged couples to seek treatments early, supporting market expansion.

2. Technological Innovations Transforming IVF

The IVF field has undergone a revolution over the last decade. Innovations include:

Time-lapse embryo imaging

AI-assisted embryo selection

Preimplantation Genetic Testing (PGT)

Advanced cryopreservation methods

Automated sperm selection systems

These advancements have significantly increased IVF success rates, minimized complications, and improved patient outcomes.

In 2023, Hamilton Thorne Nederland BV expanded its presence in Europe by acquiring Gynetics MP NV and Gynetics S BV, strengthening its product portfolio and geographical footprint in the mature ART (Assisted Reproductive Technology) market.

3. Growing Medical Tourism for IVF

Countries like India, Thailand, Spain, and Turkey have become global fertility hubs due to:

Lower treatment costs

Skilled medical professionals

Fewer legal restrictions

Advanced IVF technologies

High success rates

India alone performs 200,000–250,000 IVF cycles annually, expected to rise to 500,000–600,000 cycles by 2030, driven by affordability and highly reputed fertility centers.

Medical tourism continues to attract cross-border patients from Europe, the U.S., Africa, and the Middle East, strongly contributing to market expansion.

Market Barriers: Challenges Holding Back IVF Growth

1. High Costs of IVF Treatments

IVF remains unaffordable for many. The treatment typically requires multiple cycles, significantly increasing costs. While insurance coverage is improving in regions like North America and parts of Europe, affordability remains a major concern in developing nations.

Medication, lab procedures, donor involvement, and technology add to the financial burden, keeping IVF out of reach for low- and middle-income populations.

2. Ethical and Legal Considerations

IVF faces several ethical and legal obstacles, including:

Embryo disposal regulations

Restrictions on surrogacy

Cultural and religious objections

Concerns about genetic modification

Legal variations across countries

For instance, nations in the Middle East, parts of Africa, and several European regions have strict ART regulations, limiting the expansion of IVF services. Public stigma also continues to discourage couples from seeking help.

Segment Analysis of the IVF Market

In Vitro Fertilization: Fresh Donor Market

The demand for fresh donor eggs is rising due to:

Higher embryo quality

Improved pregnancy success rates

Growing demand for donor programs

Better donor screening and advanced matching systems have accelerated global growth in this segment.

Disposable Devices Segment

Disposable IVF devices—pipettes, culture dishes, needles—ensure sterility and minimize contamination. As global IVF procedure volumes rise, demand for high-quality disposable medical-grade tools grows significantly.

These devices are essential for maintaining standardized fertility procedures and laboratory safety, making them a major revenue segment.

Embryo Culture Media Market

Culture media play a crucial role in embryo development during IVF. Advances in single-step and sequential culture systems have increased embryo viability and implantation success. Growing fertility clinic establishments continue to boost demand for specialized media.

Fertility Clinics: The Backbone of IVF

Fertility clinics remain the primary delivery centers for IVF services. They offer:

Diagnosis

Hormone therapy

IVF and ICSI

Genetic testing

Cryopreservation

Donor programs

Global expansion in clinic networks, rising infertility cases, and increased patient awareness are driving this segment’s dominance.

Regional Outlook: IVF Market by Key Countries

United States

The U.S. remains a global leader due to:

Advanced medical infrastructure

High adoption of genetic screening

Favorable insurance coverage expansions

Presence of top fertility clinics

In September 2023, Merck launched a comprehensive Fertility Benefit Program for employees in the U.S., Canada, and Japan, fueling demand for IVF-related services.

United Kingdom

The UK’s IVF market benefits from:

NHS-funded fertility support in certain regions

Strong government initiatives

Growing technology adoption

In January 2024, the Human Fertility and Embryology Authority (HFEA) launched a first-of-its-kind online dashboard providing IVF funding transparency across the UK, improving patient access and research capabilities.

India

India is one of the most affordable and advanced IVF destinations globally. Market growth is driven by:

Increased infertility rates

Technological advancements

Improved healthcare infrastructure

Large medical tourism inflow

In February 2024, the Telangana government inaugurated a state-of-the-art IVF facility at Gandhi Hospital, marking an important step in public fertility care.

Saudi Arabia

Saudi Arabia is witnessing rapid growth due to:

Rising infertility rates

Improved healthcare infrastructure under Vision 2030

Growing cultural acceptance

Entry of international fertility providers

In September 2024, Burjeel Holdings PLC announced plans to launch IVF services in Saudi Arabia, reflecting heightened demand in the region.

IVF Market Segmentation

By Procedure Type

Fresh Non-Donor

Frozen Non-Donor

Fresh Donor

Frozen Donor

By Instruments

Disposable Devices

Culture Media

Equipment

By Technique

Intra-Cytoplasmic Sperm Injection (ICSI)

Traditional IVF

Preimplantation Genetic Testing (PGT)

Cryopreservation

Embryo Culture

By End Users

Fertility Clinics

Hospitals & Other Settings

By Region

North America: U.S., Canada

Europe: France, Germany, Italy, Spain, UK, Belgium, Netherlands, Turkey

Asia Pacific: China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand

Latin America: Brazil, Mexico, Argentina

Middle East & Africa: South Africa, Saudi Arabia, UAE

Competitive Landscape

Major IVF market players covered in the report include:

FUJIFILM Holdings Corporation

Hamilton Thorne Ltd.

Vitrolife AB

Thermo Fisher Scientific, Inc.

Bayer AG

Merck & Co., Inc.

The Cooper Companies, Inc.

Fortis Healthcare

These companies are expanding portfolios, forming strategic alliances, launching AI-enabled technologies, and investing heavily in research to improve IVF success rates globally.

Final Thoughts

The global IVF market is undergoing a transformative shift. With rising infertility, rapid technological breakthroughs, evolving legal frameworks, and booming medical tourism, IVF has become more accessible—and more necessary—than ever. By 2033, the market is set to nearly double, providing hope and solutions to growing numbers of individuals and couples seeking parenthood.

As technology and healthcare infrastructure continue to improve worldwide, the coming years may mark a new era in reproductive medicine—one where IVF becomes not just a treatment, but an integrated part of global healthcare systems.